Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00783081 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication
A Phase 2 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 387
- Enrollment target
NCT00783081: Completed Phase 2 study, sponsored by Kowa Research Institute.
NCT00783081 is a Phase 2 study that has completed, run by Kowa Research Institute. The registered enrollment target is 387 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (191% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00783081, a Phase 2 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 387 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of K-134 for the treatment of intermittent claudication.
Interventions
- DRUG Placebo
- DRUG K-134
- DRUG Cilostazol 100 mg BID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 387 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
What the finished NCT00783081 record still lists
NCT00783081 is an interventional study that assigns participants to a tested intervention. The registered 387 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (191% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00783081 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00783081 about?
NCT00783081 is a clinical study titled "Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication". The purpose of this study is to evaluate the safety and efficacy of K-134 for the treatment of intermittent claudication.
What is the current status of trial NCT00783081?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 387 participants. The study started on 2008-11. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00783081?
The interventions under investigation include: Placebo (DRUG), K-134 (DRUG), Cilostazol 100 mg BID (DRUG).
Who is sponsoring clinical trial NCT00783081?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00783081's enrollment target sits among peer trials
387 109th of 2000 higher than 1,892 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03761108 · 387 participants · Phase 1
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
- NCT05572632 · 387 participants · NA
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
- NCT06917079 · 387 participants · Phase 1
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- NCT04092010 · 388 participants · NA
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia